ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 301–312 of 2020 project topics
Pre-emptive Pharmacogenomics Testing Programs
Developing hospital-wide pre-emptive pharmacogenomics programs storing test results for use at multiple future drug prescribing decision points.
Pharmacogenetics Clinical Implementation Click to view more details →
Clinical Decision Support for PGx Results
Building electronic health record-integrated clinical decision support tools that translate pharmacogenomics results into actionable prescribing recommendations.
Pharmacogenetics Clinical Implementation Click to view more details →
Thiopurine TPMT and NUDT15 Testing Implementation
Implementing TPMT and NUDT15 pre-treatment testing for patients starting azathioprine and mercaptopurine therapy to prevent severe hematopoietic toxicity.
Pharmacogenetics Clinical Implementation Click to view more details →
Clopidogrel CYP2C19 Pharmacogenomics
Developing CYP2C19 genotype-guided antiplatelet therapy protocols for improving clopidogrel dosing and reducing adverse cardiovascular outcomes.
Pharmacogenetics Clinical Implementation Click to view more details →
Warfarin INR Dosing Optimization SaaS Platform
A cloud-based clinical decision support platform that integrates CYP2C9 and VKORC1 genotyping data to calculate personalized warfarin dosing algorithms and INR monitoring schedules. This reduces adverse bleeding events and hospitalizations, generating revenue through per-patient subscription fees and integrated EHR licensing.
Pharmacogenetics Clinical Implementation Click to view more details →
Statin Response Prediction Engine for Lipid Management
A proprietary software tool that analyzes SLCO1B1 and CYP3A4 variants to predict statin efficacy and myopathy risk, enabling personalized lipid management protocols. Hospitals and payers monetize this through improved cardiovascular outcomes, reduced statin-related muscle injury claims, and premium pricing for precision medicine workflows.
Pharmacogenetics Clinical Implementation Click to view more details →
Opioid Metabolism Risk Stratification Commercial Platform
A mobile and web application that genotypes CYP2D6 and CYP3A4 to classify patients as poor, intermediate, extensive, or ultra-rapid metabolizers and recommends opioid alternatives or dosing adjustments. Pain management clinics and addiction treatment centers gain competitive advantage and reduce overdose liability while capturing government opioid stewardship incentives.
Pharmacogenetics Clinical Implementation Click to view more details →
Antidepressant Pharmacogenomics Matching Software Service
A subscription-based matching engine using CYP2D6, CYP2C19, and CYP1A2 genotypes to recommend optimal SSRI, SNRI, and tricyclic antidepressant selections and dosing for psychiatric patients. Mental health providers and integrated care organizations increase patient remission rates and reduce medication trial-and-error costs, supporting higher insurance reimbursement rates.
Pharmacogenetics Clinical Implementation Click to view more details →
HLA-B Allele Screening Platform for Drug Safety Alerts
An automated HLA-B*5701, HLA-B*1502, and HLA-B*3101 genotyping and alert system integrated into pharmacy dispensing systems to prevent severe cutaneous adverse reactions from abacavir, carbamazepine, and allopurinol. Pharmacies and hospital systems reduce litigation costs and drug-induced hospitalization expenses while meeting regulatory compliance mandates for precision medicine.
Pharmacogenetics Clinical Implementation Click to view more details →
Tacrolimus and Voriconazole CYP3A5 Dosing Intelligence Tool
A specialized cloud analytics platform that incorporates CYP3A5 genotyping to optimize tacrolimus and voriconazole therapeutic drug monitoring and dosing in transplant and immunocompromised patient populations. Transplant centers and hospital networks reduce acute rejection episodes, invasive fungal infection mortality, and length-of-stay costs while capturing premium reimbursement for precision immunosuppressive management.
Pharmacogenetics Clinical Implementation Click to view more details →
De Novo Variant Identification in Neurodevelopmental Disorders
Applying trio exome sequencing for identifying de novo pathogenic variants in children with intellectual disability, autism, and epilepsy.
Trio Sequencing and De Novo Variant Analysis Click to view more details →
De Novo Mutation Rate Estimation
Calculating genome-wide de novo mutation rates from parent-offspring sequencing data and studying factors affecting mutation rate variation.
Trio Sequencing and De Novo Variant Analysis Click to view more details →